zaleplon has been researched along with Cognitive Decline in 1 studies
zaleplon: an azabicyclo(4.3.0)nonane; a nonbenzodiazepine; one of the so-called of Z drugs (zopiclone, eszopiclone, zolpidem, and zaleplon) for which there is some correlation with tumors; a hypnotic with less marked effect on psychomotor functions compared to lorazepam
zaleplon : A pyrazolo[1,5-a]pyrimidine having a nitrile group at position 3 and a 3-(N-ethylacetamido)phenyl substituent at the 7-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dinges, DF | 1 |
| Basner, M | 1 |
| Ecker, AJ | 1 |
| Baskin, P | 1 |
| Johnston, SL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Operational Ground Testing Protocol to Optimize Astronaut Sleep Medication Efficacy and Individual Effects[NCT03526575] | Phase 4 | 34 participants (Actual) | Interventional | 2011-01-10 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for zaleplon and Cognitive Decline
| Article | Year |
|---|---|
Effects of zolpidem and zaleplon on cognitive performance after emergent morning awakenings at Tmax: a randomized placebo-controlled trial.
Topics: Acetamides; Adult; Cognition; Cognitive Dysfunction; Cross-Over Studies; Double-Blind Method; Female | 2019 |